Antioxidants and Dementia Risk: Consideration through a Cerebrovascular Perspective

被引:17
作者
Lam, Virginie [1 ,2 ]
Hackett, Mark [1 ,3 ]
Takechi, Ryusuke [1 ,2 ]
机构
[1] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia
[2] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6845, Australia
[3] Curtin Univ, Fac Sci & Engn, Dept Chem, Perth, WA 6845, Australia
基金
英国医学研究理事会;
关键词
antioxidants; blood-brain barrier; cognitive impairment; dementia; BLOOD-BRAIN-BARRIER; AGED GARLIC EXTRACT; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALPHA-LIPOIC ACID; LIPOPOLYSACCHARIDE-INDUCED DYSFUNCTION; CEREBRAL-ISCHEMIA-REPERFUSION; AMYLOID-BETA PEPTIDE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; VITAMIN-C;
D O I
10.3390/nu8120828
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
A number of natural and chemical compounds that exert anti-oxidative properties are demonstrated to be beneficial for brain and cognitive function, and some are reported to reduce the risk of dementia. However, the detailed mechanisms by which those anti-oxidative compounds show positive effects on cognition and dementia are still unclear. An emerging body of evidence suggests that the integrity of the cerebrovascular blood-brain barrier (BBB) is centrally involved in the onset and progression of cognitive impairment and dementia. While recent studies revealed that some anti-oxidative agents appear to be protective against the disruption of BBB integrity and structure, few studies considered the neuroprotective effects of antioxidants in the context of cerebrovascular integrity. Therefore, in this review, we examine the mechanistic insights of antioxidants as a pleiotropic agent for cognitive impairment and dementia through a cerebrovascular axis by primarily focusing on the current available data from physiological studies. Conclusively, there is a compelling body of evidence that suggest antioxidants may prevent cognitive decline and dementia by protecting the integrity and function of BBB and, indeed, further studies are needed to directly examine these effects in addition to underlying molecular mechanisms.
引用
收藏
页数:18
相关论文
共 144 条
[1]   Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model [J].
Allahtavakoli, Mohammad ;
Amin, Fatemeh ;
Esmaeeli-Nadimi, Ali ;
Shamsizadeh, Ali ;
Kazemi-Arababadi, Mohammad ;
Kennedy, Derek .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (05) :335-339
[2]   Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability [J].
Allen, C. L. ;
Bayraktutan, U. .
DIABETES OBESITY & METABOLISM, 2009, 11 (05) :480-490
[3]   Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition [J].
Alluri, Himakarnika ;
Wilson, Rickesha L. ;
Shaji, Chinchusha Anasooya ;
Wiggins-Dohlvik, Katie ;
Patel, Savan ;
Liu, Yang ;
Peng, Xu ;
Beeram, Madhava R. ;
Davis, Matthew L. ;
Huang, Jason H. ;
Tharakan, Binu .
PLOS ONE, 2016, 11 (05)
[4]   Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy [J].
Amelia Santos, M. ;
Chand, Karam ;
Chaves, Silvia .
FUTURE MEDICINAL CHEMISTRY, 2016, 8 (17) :2113-2142
[5]   Lipid Lowering Agents, Cognitive Decline, and Dementia: The Three-City Study [J].
Ancelin, Marie-Laure ;
Carriere, Isabelle ;
Barberger-Gateau, Pascale ;
Auriacombe, Sophie ;
Rouaud, Olivier ;
Fourlanos, Spiros ;
Berr, Claudine ;
Dupuy, Anne-Marie ;
Ritchie, Karen .
JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (03) :629-637
[6]   Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: A novel mechanism of action [J].
Barone, Eugenio ;
Cenini, Giovanna ;
Di Domenico, Fabio ;
Martin, Sarah ;
Sultana, Rukhsana ;
Mancuso, Cesare ;
Murphy, Michael Paul ;
Head, Elizabeth ;
Butterfield, D. Allan .
PHARMACOLOGICAL RESEARCH, 2011, 63 (03) :172-180
[7]   Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients [J].
Bourdel-Marchasson, I ;
Delmas-Beauvieux, MC ;
Peuchant, E ;
Richard-Harston, S ;
Decamps, A ;
Reignier, B ;
Emeriau, JP ;
Rainfray, M .
AGE AND AGEING, 2001, 30 (03) :235-241
[8]  
Bowman Gene L, 2012, Curr Gerontol Geriatr Res, V2012, P184042, DOI 10.1155/2012/184042
[9]   Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease [J].
Cai, Zhiyou ;
Hussain, M. Delwar ;
Yan, Liang-Jun .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (05) :307-321
[10]   Major Pathogenic Mechanisms in Vascular Dementia: Roles of Cellular Stress Response and Hormesis in Neuroprotection [J].
Calabrese, Vittorio ;
Giordano, James ;
Signorile, Anna ;
Ontario, Maria Laura ;
Castorina, Sergio ;
De Pasquale, Concetta ;
Eckert, Gunter ;
Calabrese, Edward J. .
JOURNAL OF NEUROSCIENCE RESEARCH, 2016, 94 (12) :1588-1603